DSpace Repository

Do patients with major depressive disorder and generalized anxiety disorder experience more somatosensorial amplification, hypochondriasis, and fear of COVID-19?

Show simple item record

dc.creator DEMİRAY, Kadriye Ece
dc.creator ÜNAL, Onur
dc.creator ÖZDAMAR ÜNAL, Gülin
dc.date 2022-03-01T00:00:00Z
dc.date.accessioned 2023-01-09T12:07:18Z
dc.date.available 2023-01-09T12:07:18Z
dc.identifier b9e37b9d-ed52-406b-93e1-738741a844a8
dc.identifier 10.14744/dajpns.2022.00169
dc.identifier https://avesis.sdu.edu.tr/publication/details/b9e37b9d-ed52-406b-93e1-738741a844a8/oai
dc.identifier.uri http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/98299
dc.description Objective: Mental illnesses are important determinants in response to the pandemic. However, there are only a limited number of studies investigating the effects of COVID-19 in individuals with mental illnesses. We aimed to reveal the fear of COVID-19, somatosensorial amplification levels, anxiety, depression, and stress levels of patients with major depressive disorder (MDD) and generalized anxiety disorder (GAD).
dc.language eng
dc.rights info:eu-repo/semantics/closedAccess
dc.title Do patients with major depressive disorder and generalized anxiety disorder experience more somatosensorial amplification, hypochondriasis, and fear of COVID-19?
dc.type info:eu-repo/semantics/article


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account